Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation

Combined immunotherapy constitutes a novel, advanced strategy in cancer treatment. In this study, we investigated immunotherapy in the mouse TC-1/A9 model of human papillomavirus type 16 (HPV16)-associated tumors characterized by major histocompatibility complex class I (MHC-I) downregulation. We fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzelak, Adrianna, Polakova, Ingrid, Smahelova, Jana, Vackova, Julie, Pekarcikova, Lucie, Tachezy, Ruth, Smahel, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274939/
https://www.ncbi.nlm.nih.gov/pubmed/30469401
http://dx.doi.org/10.3390/ijms19113693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274939/
https://www.ncbi.nlm.nih.gov/pubmed/30469401
http://dx.doi.org/10.3390/ijms19113693

Ejemplares similares